Tissue Regenix Group (TRX) Insider Trading & Ownership GBX 58.03 -1.47 (-2.47%) (As of 10:29 AM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider Trades Tissue Regenix Group (LON:TRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage47.34%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)£50,321.92Number OfInsiders Selling(Last 3 Years)0 Get TRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tissue Regenix Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRX Insider Buying and Selling by Quarter Ad Crypto 101 MediaAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectDiscover our #1 crypto pick before it's too late. Tissue Regenix Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2023Brian PhillipsInsiderBuy6,773GBX 54£3,657.424/4/2023Daniel LeeInsiderBuy500,000GBX 1£5,0004/19/2022Trevor PhillipsInsiderBuy2,758,000GBX 1£27,58012/22/2021Daniel LeeInsiderBuy1,408,450GBX 1£14,084.50 (Data available from 1/1/2013 forward) TRX Insider Trading Activity - Frequently Asked Questions Who is on Tissue Regenix Group's Insider Roster? The list of insiders at Tissue Regenix Group includes Brian Phillips, Daniel Lee, and Trevor Phillips. Learn more on insiders at TRX. What percentage of Tissue Regenix Group stock is owned by insiders? 47.34% of Tissue Regenix Group stock is owned by insiders. Learn more on TRX's insider holdings. Which Tissue Regenix Group insiders have been buying company stock? The following insiders have purchased TRX shares in the last 24 months: Brian Phillips (£3,657.42), and Daniel Lee (£5,000). How much insider buying is happening at Tissue Regenix Group? Insiders have purchased a total of 506,773 TRX shares in the last 24 months for a total of £8,657.42 bought. Tissue Regenix Group Key ExecutivesMr. Daniel Ray Lee (Age 63)CEO & Director Compensation: $488.78kMr. David Claiborne Cocke (Age 59)CFO & Executive Director Compensation: $288.86kMs. Christine RowleyTechnical & Operations Director - UKTina TrimbleSenior Vice President, Donor Services - U.S.Ms. Kirsten Mary LundEMEA Business Director & Company Secretary More Insider Trading Tools from MarketBeat Related Companies Severfield Insider Ownership National Grid Insider Ownership 4basebio Insider Ownership e-therapeutics Insider Ownership Poolbeg Pharma Insider Ownership Sareum Insider Ownership Oncimmune Insider Ownership BiVictriX Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:TRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
